Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol

Joint Authors

Safdar, Zeenat
Abughazaleh, Shaadi

Source

Case Reports in Pulmonology

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-4, 4 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-01-23

Country of Publication

Egypt

No. of Pages

4

Main Subjects

Diseases

Abstract EN

A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter.

In patients treated with epoprostenol for long periods of time, thyroid disease is common.

Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.

American Psychological Association (APA)

Abughazaleh, Shaadi& Safdar, Zeenat. 2020. Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol. Case Reports in Pulmonology،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1150994

Modern Language Association (MLA)

Abughazaleh, Shaadi& Safdar, Zeenat. Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol. Case Reports in Pulmonology No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1150994

American Medical Association (AMA)

Abughazaleh, Shaadi& Safdar, Zeenat. Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol. Case Reports in Pulmonology. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1150994

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1150994